Actively Recruiting
Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-10-18
550
Participants Needed
1
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators' primary objective is to assess whether a difference in the occurrence of bleeding events exist between patients with LVT treated with DOACs as compared to those treated with VKAs.
CONDITIONS
Official Title
Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients at least 18 years old at enrolment
- Diagnosed with left ventricular thrombus by echocardiography, MRI, or CT between January 1, 2013 and July 31, 2020
- Treated at least once at Inselspital or another Insel Gruppe site
- Able to provide written informed consent
You will not qualify if you...
- Documented refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Cardiology, University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
C
Christoph Gräni, Prof. PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here